Pancreatic Cancer Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 20 years old or older
- You are willing and able to sign and date a consent form agreeing to take part
- You are willing to follow all the steps of the registry and are available for the full duration of the study
- You have been diagnosed with pancreatic cancer (confirmed by tissue testing) in any part of the pancreas
- Your pancreatic tumor is suitable to be treated with focused ultrasound (FUS), a type of sound wave therapy
- You are willing and able to complete follow-up check-ins during the study
- You have already agreed to take part in a related clinical trial (reference number 201701032DIPD) and are scheduled to receive focused ultrasound therapy at the study hospital
Who may not be able to join:
- You have a disease, condition, or have had a surgery that means focused ultrasound treatment would not be safe or suitable for you (confirm with trial site)
- You are currently taking part in a different clinical trial for pancreatic cancer that does not involve focused ultrasound or related treatments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kai-Wen Huang, M.D. Ph.D, National Taiwan University Hospital
Phone: 886-2-23123456
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Pain related to pancreatic cancer; To observe the efficacy of local tumor ablation; The effect of local tumor ablation; To observe the survival rate; To observe the progression-free survival rate; To evaluate clinical benefit response (CBR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.